ChemoMetec A/S (CO:CHEMM) — Market Cap & Net Worth
Market Cap & Net Worth: ChemoMetec A/S (CHEMM)
ChemoMetec A/S (CO:CHEMM) has a market capitalization of $1.33 Billion (Dkr8.48 Billion) as of August 24, 2026. Listed on the CO stock exchange, this Denmark-based company holds position #7747 globally and #43 in its home market, demonstrating a 2.14% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ChemoMetec A/S's stock price Dkr487.40 by its total outstanding shares 17402479 (17.40 Million). Check ChemoMetec A/S stock quote for real-time trading data and today's change.
ChemoMetec A/S Market Cap History: 2015 to 2026
ChemoMetec A/S's market capitalization history from 2015 to 2026. Data shows growth from $99.41 Million to $1.33 Billion (34.29% CAGR).
ChemoMetec A/S Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ChemoMetec A/S's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check CHEMM net asset value to evaluate the company's book value and shareholders' equity.
Latest Price to Sales (P/S) Ratio
3.78x
ChemoMetec A/S's market cap is 3.78 times its annual revenue
Latest Price to Earnings (P/E) Ratio
10.04x
ChemoMetec A/S's market cap is 10.04 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $89.34 Million | $85.23 Million | $10.48 Million | 1.05x | 8.52x |
| 2017 | $67.91 Million | $90.33 Million | $7.49 Million | 0.75x | 9.07x |
| 2018 | $221.54 Million | $112.69 Million | $18.21 Million | 1.97x | 12.16x |
| 2019 | $558.16 Million | $175.51 Million | $41.84 Million | 3.18x | 13.34x |
| 2020 | $1.57 Billion | $214.10 Million | $59.16 Million | 7.35x | 26.60x |
| 2021 | $2.27 Billion | $281.13 Million | $88.35 Million | 8.07x | 25.67x |
| 2022 | $1.88 Billion | $428.39 Million | $159.47 Million | 4.39x | 11.79x |
| 2023 | $1.06 Billion | $444.40 Million | $178.67 Million | 2.38x | 5.91x |
| 2024 | $1.32 Billion | $407.87 Million | $136.28 Million | 3.25x | 9.71x |
| 2025 | $1.87 Billion | $495.57 Million | $186.41 Million | 3.78x | 10.04x |
Competitor Companies of CHEMM by Market Capitalization
Companies near ChemoMetec A/S in the global market cap rankings as of August 24, 2026. Also see cash efficiency ratio of ChemoMetec A/S for how efficiently the company converts equity into cash flow.
Key companies related to ChemoMetec A/S by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #105 globally with a market cap of $196.11 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #195 globally with a market cap of $126.37 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #232 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #249 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #105 | Abbott Laboratories | NYSE:ABT | $196.11 Billion | $116.64 |
| #195 | Stryker Corporation | NYSE:SYK | $126.37 Billion | $329.45 |
| #232 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $93.35 |
| #249 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
ChemoMetec A/S Historical Marketcap From 2015 to 2026
Between 2015 and today, ChemoMetec A/S's market cap moved from $99.41 Million to $ 1.33 Billion, with a yearly change of 34.29%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Dkr1.33 Billion | -29.11% |
| 2025 | Dkr1.87 Billion | +41.40% |
| 2024 | Dkr1.32 Billion | +25.31% |
| 2023 | Dkr1.06 Billion | -43.81% |
| 2022 | Dkr1.88 Billion | -17.11% |
| 2021 | Dkr2.27 Billion | +44.12% |
| 2020 | Dkr1.57 Billion | +181.95% |
| 2019 | Dkr558.16 Million | +151.94% |
| 2018 | Dkr221.54 Million | +226.24% |
| 2017 | Dkr67.91 Million | -23.99% |
| 2016 | Dkr89.34 Million | -10.13% |
| 2015 | Dkr99.41 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 24th, 2026 the market cap of ChemoMetec A/S was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.33 Billion USD |
| MoneyControl | $1.33 Billion USD |
| MarketWatch | $1.33 Billion USD |
| marketcap.company | $1.33 Billion USD |
| Reuters | $1.33 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About ChemoMetec A/S
ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in the areas of cell and gene therapy, cancer and stem cell research, and development and manufacturing of pharmaceuticals, as well as production and quality control of animal semen, milk, an… Read more